ABOUT ADVANCING RNA

Advancing RNA is a Life Science Connect community focused on the rapidly evolving field of RNA-based therapeutics. It aims to provide valuable insights, discussions, and resources for professionals developing RNA-based drugs. Primary members of the community consist of individuals from biopharma organizations engaged in pre-BLA development, often in the pre-IND discovery stage. The community addresses various challenges in RNA therapy development, including analytical, quality, manufacturing, and regulatory issues. Additionally, Advancing RNA is positioned within the broader Life Science Connect network, allowing members to access additional resources as needed for their RNA therapy development journey.

AUTHORITY

Anna Rose has dedicated the past nine years of her professional journey to mastering the intricate aspects of the biologics field, including science, regulations, development, and policy. Anna's unique perspective has granted her unparalleled insights into the most pressing challenges and promising opportunities within this sector. Anna has previously served as the Chief Editor of two Life Science Connect Communities, Biosimilar Development and the Cell & Gene Collaborative. Before assuming those leadership roles, she covered daily news stories for Life Science Connect. She is now entrusted with various pivotal roles, such as moderating discussions, chairing and orchestrating international conferences, presenting alongside industry experts on noteworthy emerging developments, and facilitating multi-stakeholder dialogues across the globe.

Connect with Anna Rose on LinkedIn: 
https://www.linkedin.com/in/annarosewelch/

CONTACT ADVANCING RNA

Advancing RNA is a product of Life Science Connect, a division of VertMarkets.

• Join the Advancing RNA community
• Email general questions
• Submit/propose an article
• Request a media kit
• Join our team

Office Locations